文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

改良内镜逆行阑尾炎治疗术与单纯抗生素治疗儿童急性非复杂性阑尾炎的随机对照研究

The modified endoscopic retrograde appendicitis therapy versus antibiotic therapy alone for acute uncomplicated appendicitis in children.
PubMed 文献 · Surg Endosc · 2020-11-04

这项前瞻性随机对照试验纳入83例儿童急性非复杂性阑尾炎患者,比较改良内镜逆行阑尾炎治疗术(mERAT)与常规抗生素治疗的疗效。结果显示mERAT组治疗成功率100%显著高于抗生素组80.9%(P=0.004),且中位出院时间显著缩短(6.0±1.76天,P=0.004)。mERAT为不愿接受阑尾切除术的家庭提供了新的治疗选择。

要点

  • mERAT治疗儿童急性非复杂性阑尾炎成功率100%,显著高于抗生素组的80.9%。
  • mERAT组中位出院时间6.0±1.76天,显著短于抗生素组。
  • mERAT组无显著并发症,抗生素组有9例应答不佳转为mERAT。

核心结论

  • mERAT为儿童急性非复杂性阑尾炎提供了新的替代治疗选择,尤其适用于不愿接受阑尾切除术的家庭。

研究设计与样本

  • 前瞻性随机对照临床试验,2018年10月至2020年2月连续纳入83例经超声和/或腹部CT确诊的急性非复杂性阑尾炎儿童,随机分为mERAT组(36例)和抗生素组(47例),随访至2020年5月。

主要发现

  • mERAT组所有患儿均经内镜确诊为急性非复杂性阑尾炎,无显著并发症。
  • 抗生素组9例治疗应答不佳转为mERAT。
  • mERAT组总体治疗成功率100%,显著高于抗生素组的80.9%(P=0.004)。
  • mERAT组中位出院时间6.0±1.76天,显著短于抗生素组(P=0.004)。

关键数值与推荐

  • 主要结局指标为治疗后腹痛缓解持续时间。
  • mERAT组治疗成功率100%,抗生素组80.9%(P=0.004)。
  • mERAT组中位出院时间6.0±1.76天(P=0.004)。

临床怎么用

  • 对于儿童急性非复杂性阑尾炎,mERAT可作为抗生素治疗的有效替代方案,尤其适用于不愿手术的家庭。
  • 采用超声造影替代内镜逆行阑尾造影以避免儿童电离辐射相关恶性肿瘤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic retrograde appendicitis therapy (ERAT) is an emerging endoscopic treatment modality for acute uncomplicated appendicitis (AUA) supported by several case series. However, to date, systematic studies have not been conducted in children and the prospective comparative data are lacking. Moreover, due to a concern for future malignancy risk in children from ionizing radiation, we used contrast-enhanced ultrasound (CEUS) instead of endoscopic retrograde appendiceal radiography (ERAR). Therefore, we conducted a prospective, randomized control clinical trial to compare the modified ERAT (mERAT) to antibiotic therapy in children with AUA. The aim of this study was to evaluate the safety and feasibility and of mERAT in the treatment of hospitalized children with AUA. METHODS: Children with AUA, confirmed by ultrasonography and or abdominal computed tomography, were consecutively enrolled from October 2018 to February, 2020. They were randomly assigned to receive mERAT or routine antibiotic treatment. Patients were followed until May, 2020. Th primary outcome variable was the duration of relief of the abdominal pain after treatment. We collected patient's demographics, ultrasonic imaging findings, colonoscopy findings, and treatment outcomes of the mERAT and adverse even associated with mERAT. RESULTS: A total of 83 children were enrolled. 36 were randomized to mERAT and 47 to antibiotics treatment. All children in the mERAT group had endoscopic confirmed acute uncomplicated appendicitis, and there were no significant complications. However, 9 of patients in antibiotic group were poor responsive to treatment and switched to mERAT. The overall success rate of treatment with mERAT (100%) was significantly higher than that of antibiotics (80.9%) (P = 0.004). The median time to discharge was significantly shorter in mERAT group than in antibiotics treatment group [6.0 ± 1.76 days] (P = 0.004). CONCLUSIONS: mERAT provide a new alternative therapeutic option for childhood with AUA, especially for families who are reluctant to undergo an appendectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kang J, Zhang W, Zeng L, et al. The modified endoscopic retrograde appendicitis therapy versus antibiotic therapy alone for acute uncomplicated appendicitis in children. Surg Endosc. 2020. PMID: 33146811. doi:10.1007/s00464-020-08129-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。